Drug Profile
Research programme: hepatitis B DNA vaccine - Virax
Alternative Names: Therapeutic HBV Vaccine - Virax; VIR 401Latest Information Update: 10 Jan 2011
Price :
$50
*
At a glance
- Originator Virax Holdings
- Developer Prescient Therapeutics
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Hepatitis B